Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL63623 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL5516547 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL6899785 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL25341592 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL18531126 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL23879492 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL5580131 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL571313 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL19148651 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 | |
| SCHEMBL29209211 | 1.00 | CPB2 (0.58) | CPB2CA2ZDHHC7CA1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3113847-B1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | KAO GERMANY GMBH (DE) | 2019-11-20 | — | — | EP | claimed |
| EP-3113848-B1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | KAO GERMANY GMBH (DE) | 2018-10-31 | — | — | EP | claimed |
| US-9776021-B2 | Anhydrous dyeing composition and process for dyeing hair | KAO GERMANY GMBH (DE) | 2017-10-03 | — | — | US | claimed |
| US-9737475-B2 | Anhydrous dyeing composition and process for dyeing hair | KAO GERMANY GMBH (DE) | 2017-08-22 | — | — | US | claimed |
| EP-3113847-A1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | Kao Germany GmbH (DE) | 2017-01-11 | — | — | EP | claimed |
| EP-3113848-A1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | Kao Germany GmbH (DE) | 2017-01-11 | — | — | EP | claimed |
| US-20160213601-A1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | KAO GERMANY GMBH (DE) | 2016-07-28 | — | — | US | claimed |
| US-20160199291-A1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | KAO GERMANY GMBH (DE) | 2016-07-14 | — | — | US | claimed |
| WO-2015188841-A1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | KAO GERMANY GMBH (DE) | 2015-12-17 | — | — | WO | claimed |
| WO-2015185069-A1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | KAO GERMANY GMBH (DE) | 2015-12-10 | — | — | WO | claimed |
| CN-116963714-A | Cosmetic product | 信越化学工业株式会社 | 2023-10-27 | — | — | CN | disclosed |
| US-11666618-B2 | Method for selective extraction of cannabinoids from a plant source | YISSUN RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2023-06-06 | — | — | US | disclosed |
| US-11224628-B2 | Method for extraction of an agent from a plant source | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2022-01-18 | — | — | US | disclosed |
| US-20210189444-A1 | METHOD OF PURIFYING CANNABINOIDS FROM YEAST FERMENTATION BROTH | DEMETRIX, INC. | 2021-06-24 | — | — | US | disclosed |
| EP-3113753-B1 | AQUEOUS OXIDIZING COMPOSITION FOR HAIR | KAO GERMANY GMBH (DE) | 2021-06-16 | — | — | EP | disclosed |
| EP-2191865-A1 | Process for colouring and straightening keratin fibres | KPSS-Kao Professional Salon Services GmbH (DE) | 2010-06-02 | — | — | EP | disclosed |
| EP-2191864-A1 | Process for colouring and straightening keratin fibres | KPSS-Kao Professional Salon Services GmbH (DE) | 2010-06-02 | — | — | EP | disclosed |
| EP-2129732-A1 | LOW YELLOWING OVERPRINT VARNISHES | Sun Chemical Corporation (US) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008122593-A1 | LOW YELLOWING OVERPRINT VARNISHES | SUN CHEMICAL CORPORATION (US) | 2008-10-16 | — | — | WO | disclosed |
| WO-2004007073-A1 | SUPPORTED CATALYST | JOHNSON MATTHEY PLC (GB) | 2004-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11224628-B2 | Method for extraction of an agent from a plant source | LIPA, PHOSPHO1, SGMS1 | CPB2 2050/4885CA2 2786/4885ZDHHC7 1499/4885 |
| US-20160213601-A1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | SHH, S100P, S100B | CPB2 4305/4885CA2 326/4885ZDHHC7 271/4885 |
| US-20160199291-A1 | ANHYDROUS DYEING COMPOSITION AND PROCESS FOR DYEING HAIR | SHH, TYR, ALDH1A3 | CPB2 4616/4885CA2 629/4885ZDHHC7 384/4885 |
| US-11666618-B2 | Method for selective extraction of cannabinoids from a plant source | CNR2, CNR1, FAAH | CPB2 1590/4885CA2 2774/4885ZDHHC7 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.